Q1 2022 Holdings
Filed 2022-05-13 | 54 holdings | $206.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $15.5M | 898,631 | 7.5% |
| Celldex Therapeutics Inc(CLDX) | Common | 15117B202 | $21.4M | 628,356 | 10.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $51.9M | 442,502 | 25.2% |
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $71.3M | 4,220,048 | 34.6% |